Schell C, Lantermann O, Popp W, Vahrenholz C, Thomale J, Gugova R, Golovinsky E, Norpoth K
Institute of Hygiene and Occupational Medicine, University Medical Center, Essen, Germany.
J Cancer Res Clin Oncol. 1994;120(7):403-8. doi: 10.1007/BF01240139.
Five different representatives (I-V) of a new class of bifunctional alkylating agents, the 4-aroyl-1-nitrosohydrazinecarboxamides ("nitrososemicarbazides"), were evaluated for their potential interaction with DNA and for their cytotoxic activity in vitro to O6-alkylguanine-DNA alkyltransferase-positive (Mer+) and -negative (Mer-) human cell lines. The HeLa MR cell line (Mer-) showed up to 20-fold higher sensitivity at IC50 (dose that inhibits colony formation by 50%) to agents I-V than did the HeLa S3 cell line (Mer+) in a colony-formation assay. These data were compared to those obtained by treatment of the two cell lines with carmustine, a currently used antitumor drug. In Mer+ cells comparable results to those with carmustine were obtained with compounds III, IV and V; in Mer- cells compounds I and II showed nearly the same effects as carmustine. Whether compounds I-V produce DNA strand breaks and/or DNA-protein cross-links was investigated using an alkaline filter elution technique. In this assay all compounds produced DNA single-strand breaks; no correlation could be detected between the strand breakage frequency and cytostatic, mutagenic and antitumor activity.
对一类新型双功能烷基化剂——4-芳酰基-1-亚硝基肼甲酰胺(“亚硝基氨基脲”)的五种不同代表物(I-V)进行了评估,以研究它们与DNA的潜在相互作用以及在体外对O6-烷基鸟嘌呤-DNA烷基转移酶阳性(Mer+)和阴性(Mer-)人细胞系的细胞毒性活性。在集落形成试验中,HeLa MR细胞系(Mer-)对试剂I-V的IC50(抑制集落形成50%的剂量)敏感性比HeLa S3细胞系(Mer+)高20倍。将这些数据与用卡莫司汀(一种目前使用的抗肿瘤药物)处理这两种细胞系所获得的数据进行比较。在Mer+细胞中,化合物III、IV和V获得了与卡莫司汀相当的结果;在Mer-细胞中,化合物I和II显示出与卡莫司汀几乎相同的效果。使用碱性滤膜洗脱技术研究了化合物I-V是否产生DNA链断裂和/或DNA-蛋白质交联。在该试验中,所有化合物均产生DNA单链断裂;未检测到链断裂频率与细胞生长抑制、诱变和抗肿瘤活性之间的相关性。